Fragment-based lead discovery is a novel lead discovery method. Scientists use this technology to screen much lower molecular weight (100-300 Da) compounds relative to HTS campaigns. Fragment-based hits are typically weak inhibitors which need to be screened at higher concentration using very sensitive biophysical detection techniques. In order to improve the Rule of Three parameters, BOC Sciences has prepared a high quality HTS Compound Collection which owns structurally-diverse screening compounds to help build the Ultimate Fragment Library that can cover broad chemical space and possess optimal physicochemical properties for medicinal chemistry and drug discovery projects.
Figure 1. Schematic depicting how a poised fragment library can be used to rapidly synthesize a follow-up library of analogues. (Cox, O. B.; et al. 2016)
BOC Sciences has developed an Ultimate Fragment Library by obeying a heuristic rule called the Rule of Three. Various methods are applied to refine the fragment-like molecule collection, resulting in around 10,000 drug-like fragments. Physicochemical parameters of our well-designed Ultimate Fragment Library are summarized in the table below:
Table1. The summary of the BOC Sciences Ultimate Fragment Library characteristics
Parameter | Value |
MW | 150-300 |
ClogP | -2-3 |
Number of Rotatable Bonds | ≤3 |
Number of H Donors | ≤3 |
Number of H Acceptors | ≤3 |
PSA | ≤80 |
Number of Rings | 1-3 |
LogSw | >-5 |
Sum of Halogen Atoms | ≤1 |
Compounds with ‘undesirable’ functionalities | Removed |
Fsp3 | <1 |
Benzene rings | ≤1 |
S atoms | ≤1 |
BOC Sciences provides professional, rapid and high-quality services of Ultimate Fragment Library design at competitive prices for global customers. Personalized and customized services of Ultimate Fragment Library design an satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.